Cargando…
Quantifying the Ki-67 Heterogeneity Profile in Prostate Cancer
Background: Ki-67 is a robust predictive/prognostic marker in prostate cancer; however, tumor heterogeneity in prostate biopsy samples is not well studied. Methods: Using an MRI/US fusion device, biopsy cores were obtained systematically and by targeting when indicated by MRI. Prostate cores contain...
Autores principales: | Mesko, Shane, Kupelian, Patrick, Demanes, D. Jeffrey, Huang, Jaoti, Wang, Pin-Chieh, Kamrava, Mitchell |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816071/ https://www.ncbi.nlm.nih.gov/pubmed/24222860 http://dx.doi.org/10.1155/2013/717080 |
Ejemplares similares
-
Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation
por: Soares, Andreia, et al.
Publicado: (2010) -
Predictors of distant metastasis after combined HDR brachytherapy and external beam radiation for prostate cancer
por: Kamrava, Mitchell, et al.
Publicado: (2013) -
Significance of p53 and ki-67 expression in prostate cancer
por: Verma, Renuka, et al.
Publicado: (2015) -
Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021) -
Ki67—An unsuitable marker of gastric cancer prognosis unmasks intratumoral heterogeneity
por: Böger, Christine, et al.
Publicado: (2015)